TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/20/18 08:40 | 12/18/18 | BTX | Biotime Inc | CA | Health | BioPrd | Biological Products, (No Diag | Skibsted Russell | CA | O | CFO | M.d | 0 | 0.00 | 0 | 23 | 999% | 24 | D | ||||||||||||||
10/9/18 19:18 | 10/4/18 | BTX | Biotime Inc | CA | Health | BioPrd | Biological Products, (No Diag | Skibsted Russell | CA | O | CFO | M.d | 0 | 0.00 | 0 | 11 | 9 | D | |||||||||||||||
8/25/17 16:33 | 8/23/17 | BTX | Biotime Inc | CA | Health | BioPrd | Biological Products, (No Diag | Skibsted Russell | CA | O | CFO | P | 5 | 2.64 | 0 | 2 | New | 2 | D | ||||||||||||||
5/23/12 19:22 | 5/23/12 | AOLS | Aeolus Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Skibsted Russell | CA | O | CFO | P | 2 | 0.2388 | 0 | 7 | 70 | 17 | D | ||||||||||||||
5/19/11 17:05 | 5/18/11 | AOLS | Aeolus Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Skibsted Russell | CA | O | CFO | P | 8 | 0.4225 | 0 | 20 | New | 20 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |